Provision of health care for cystic fibrosis Diagnosing a new case of cystic fibrosis means much more than just a series of episodic interventions to deal with chest infection and the many other clinical incidents and crises which may occur. It means that the patient is enrolled into a programme of management which will continue for life and involve a variety of health care professionals. Nor is cystic fibrosis simply another incurable disease, because there is now a real prospect that definitive therapy capable of controlling the underlying metabolic defect may emerge during the lifetime ofaffected children. There is therefore every reason for a cautiously optimistic, but active, interventionist approach using currently available treatment. Recent genetic developments have opened up the possibility of prenatal diagnosis, while improvements in neonatal screening methods offer the possibility of diagnosis before major lung damage has occurred. Although at present such damage may not be preventable, experience suggests that it can be limited and delayed. The current clinical management of cystic fibrosis was discussed at a symposium held in February by the RSM's Section of Paediatrics, and the proceedings are published this month in a special supplement to the JRSM'.
Major contributions to the programme ofcare come from paramedical members of the team, including nurses, physiotherapists and dietitians. The social, and often the emotional consequences of the disease are best handled by a specialist social worker, who may be able to arrange practical support for the family while the child is young, and in later life for the adolescent and the adult. The knowledge, experience and skills required are likely to be found only in a limited number of centres, but are analogous to the expertise required for the care of other handicapping disorders such as cerebral palsy and spina bifida. The case for special centres for the care of cystic fibrosis patients has been presented elsewhere26 and applied in countries throughout the world.
It is perhaps surprising that this principle has taken so long to gain acceptance in the United Kingdom, which has one of the most unified systems of health care anywhere in the world, and which lends itSelf to organization of services on a regional basis. Perhaps in this respect the National Health Service is still dominated by local medical professional interests which can override the requirements of patients and reduce their ability to shop around. Paradoxically, in a free market system pressures for particular health services may be responded to more readily, with less bureaucratic inertia to overcome. VVhatever may be the reasons, the organization ofcystic fibrosis care in the UK lags some way behind that of many other developed countries, including those with the most impressive results in terms of survival.
In recognized cystic fibrosis centres in North America, enrolled patients qualify for a variety of financial benefits including free prescriptions. By contrast, in the UK relief from prescriptions charges for adults applies to only a handful of chronic disorders, such as diabetes, and the list of such conditions -which does not include cystic fibrosis -is long overdue for revision or abandonment. It is incongruous that the 10% or so ofadult cystic fibrosis patients with diabetes qualify, while the remainder do not. Local health district policy will determine whether patients on home intravenous therapy receive their drugs from hospital, in which case they may or may not have to pay prescription charges, or more conveniently through their local pharmacist in which case prescription charges would apply. Much more importantly, there is wide variation in the granting of attendance allowance to parents. These allowances are not given on grounds of financial hardship, but according to the degree of medical disability and at the discretion of local assessors who may or may not be familiar with the disease. Responsibility for such assessment could well be delegated to recognized cystic fibrosis centres, if such existed.
The Secretary ofState for Health & Social Services is to be applauded for his willingness to look at the services for AIDS in the United States and to apply the lessons learned to provision of care for AIDS victims in the UK. This open-minded approach could be extended to other problems, particularly that of cystic fibrosis, with great benefit.
